Clinical Trial

Early Detection & Intervention of Cerebral Palsy in Ireland

Recruiting
View on ClinicalTrials.gov →
Summary
Cerebral palsy (CP) is the most common lifelong physical disability. It is defined as a non-progressive disorder of movement originating from neural lesions in the perinatal period, and is associated with a wide range of common comorbidities in many individuals. These include problems speaking, hearing, seeing, thinking, feeding and controlling their bladder. People with CP often have additional challenges such as behavioural and emotional issues, pain, and poor sleep. Many of these challenges respond well to intervention in early childhood, as brain plasticity is at its greatest in the first 2 years of life. However, in most clinical settings, the age for diagnosis of CP is between 24 to 29 months, after this window of neurodevelopmental opportunity. This project will aim to improve the Early Detection of Cerebral Palsy in Ireland. This will be achieved by implementing an evidence-based approach to follow-up of High risk infants.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-06-15; most recent amendment 2023-09-28.
Status change: Not Yet Recruiting → Recruiting 2023-09-28
Trial Details
NCT Number NCT05907837
Lead Sponsor University College Cork
Collaborators: National Maternity Hospital, Ireland, University Maternity Hospital Limerick, Cork University Maternity Hospital, Coombe Women and Infants University Hospital, The Rotunda Hospital, Cerebral Palsy Foundation
Conditions Cerebral Palsy, Neurodevelopmental Disorders
Enrollment 1,500 participants
Start Date 2023-07-01
Primary Completion 2027-06-30 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2023-10-02